{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:59:55Z","timestamp":1773802795406,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-026-00528-0","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:26:15Z","timestamp":1770801975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, treatment strategies, and long-term outcomes of Blau syndrome: a 10-year experience from a Chinese cohort"],"prefix":"10.1186","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3524-2590","authenticated-orcid":false,"given":"Jingyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1912-126X","authenticated-orcid":false,"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"528_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","volume":"107","author":"EB Blau","year":"1985","unstructured":"Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689\u201393. https:\/\/pubmed.ncbi.nlm.nih.gov\/4056967.","journal-title":"J Pediatr"},{"key":"528_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1546-0096-12-33","volume":"12","author":"CH Wouters","year":"2014","unstructured":"Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33. https:\/\/doi.org\/10.1186\/1546-0096-12-33.","journal-title":"Pediatr Rheumatol Online J"},{"key":"528_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","volume":"54","author":"CD Ros\u00e9","year":"2015","unstructured":"Ros\u00e9 CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54:1008\u201316. https:\/\/doi.org\/10.1093\/rheumatology\/keu437.","journal-title":"Rheumatology (Oxford)"},{"key":"528_CR4","first-page":"373","volume":"32","author":"CD Ros\u00e9","year":"2005","unstructured":"Ros\u00e9 CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP, et al. Blau syndrome mutation of CARD15\/NOD2 in sporadic early onset granulomatous arthritis. J Rhuematol. 2005;32:373\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/15693102.","journal-title":"J Rhuematol"},{"key":"528_CR5","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1080\/09273948.2023.2293922","volume":"32","author":"EO Kreps","year":"2024","unstructured":"Kreps EO, Al Julandani D, Guly CM, Arostegui JI, Dick AD, Ramanan AV. Long-Term visual outcome of patients with Blau syndrome. Ocul Immunol Inflamm. 2024;32:1728\u201332. https:\/\/doi.org\/10.1080\/09273948.2023.2293922.","journal-title":"Ocul Immunol Inflamm"},{"key":"528_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/art.24134","volume":"60","author":"I Okafuji","year":"2009","unstructured":"Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009;60:242\u201350. https:\/\/doi.org\/10.1002\/art.24134.","journal-title":"Arthritis Rheum"},{"key":"528_CR7","first-page":"396","volume":"23","author":"SK Saini","year":"1996","unstructured":"Saini SK, Rose CD. Liver involvement in Familial granulomatous arthritis (Blau syndrome). J Rhuematol. 1996;23:396\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/8882056.","journal-title":"J Rhuematol"},{"key":"528_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0022-3476(98)70286-0","volume":"133","author":"SS Ting","year":"1998","unstructured":"Ting SS, Ziegler J, Fischer E. Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr. 1998;133:450\u20132. https:\/\/pubmed.ncbi.nlm.nih.gov\/9738733.","journal-title":"J Pediatr"},{"key":"528_CR9","first-page":"2504","volume":"34","author":"A Emaminia","year":"2007","unstructured":"Emaminia A, Nabavi M, Mousavi Nasab M, Kashef S. Central nervous system involvement in Blau syndrome: a new feature of the syndrome? J Rhuematol. 2007;34:2504\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/18061972.","journal-title":"J Rhuematol"},{"key":"528_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1684\/ejd.2008.0510","volume":"18","author":"V Dhondt","year":"2008","unstructured":"Dhondt V, Hofman S, Dahan K, Beele H. Leg ulcers: a new symptom of Blau syndrome? Eur J Dermatology: EJD. 2008;18:635\u20137. https:\/\/doi.org\/10.1684\/ejd.2008.0510.","journal-title":"Eur J Dermatology: EJD"},{"key":"528_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1749-8090-5-16","volume":"5","author":"F Mourad","year":"2010","unstructured":"Mourad F, Tang A. Sinus of Valsalva aneurysm in blau\u2019s syndrome. J Cardiothorac Surg. 2010;5:16. https:\/\/doi.org\/10.1186\/1749-8090-5-16.","journal-title":"J Cardiothorac Surg"},{"key":"528_CR12","doi-asserted-by":"publisher","first-page":"xviii","DOI":"10.1016\/j.ajo.2017.12.006","volume":"187","author":"Holland","year":"2018","unstructured":"Holland GN, Rosenbaum JT. The challenge of Blau syndrome. Am J Ophthalmol. 2018;187:xviii\u2013xvxix. https:\/\/doi.org\/10.1016\/j.ajo.2017.12.006.","journal-title":"Am J Ophthalmol"},{"key":"528_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.autrev.2014.08.010","volume":"13","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13:1220\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.010.","journal-title":"Autoimmun Rev"},{"key":"528_CR14","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1002\/art.22122","volume":"54","author":"CD Ros\u00e9","year":"2006","unstructured":"Ros\u00e9 CD, Wouters CH, Meiorin S, Doyle TM, Davey MP, Rosenbaum JT, et al. Pediatric granulomatous arthritis: an international registry. Arthritis Rheum. 2006;54:3337\u201344. https:\/\/pubmed.ncbi.nlm.nih.gov\/17009307.","journal-title":"Arthritis Rheum"},{"key":"528_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.semarthrit.2017.09.010","volume":"47","author":"L Lu","year":"2018","unstructured":"Lu L, Shen M, Jiang D, Li Y, Zheng X, Li Y, et al. Blau syndrome with good reponses to tocilizumab: A case report and focused literature review. Semin Arthritis Rheum. 2018;47:727\u201331. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.010.","journal-title":"Semin Arthritis Rheum"},{"key":"528_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13075-019-2017-5","volume":"21","author":"J Chen","year":"2019","unstructured":"Chen J, Luo Y, Zhao M, Wu D, Yang Y, Zhang W, et al. Effective treatment of TNFalpha inhibitors in Chinese patients with Blau syndrome. Arthritis Res Ther. 2019;21:236. https:\/\/doi.org\/10.1186\/s13075-019-2017-5.","journal-title":"Arthritis Res Ther"},{"key":"528_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12887-025-05584-x","volume":"25","author":"X Shi","year":"2025","unstructured":"Shi X, Deng J, Zhang J, Zhao X, Zhao Y, Li L, et al. Long-term prognosis of 47 pediatric patients with Blau syndrome in China. BMC Pediatr. 2025;25:374. https:\/\/doi.org\/10.1186\/s12887-025-05584-x.","journal-title":"BMC Pediatr"},{"key":"528_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, H\u00e4fner R, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19\u201320. https:\/\/pubmed.ncbi.nlm.nih.gov\/11528384.","journal-title":"Nat Genet"},{"key":"528_CR19","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"N Kanazawa","year":"2004","unstructured":"Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2004;105:1195\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/15459013.","journal-title":"Blood"},{"key":"528_CR20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/art.24533","volume":"60","author":"CD Ros\u00e9","year":"2009","unstructured":"Ros\u00e9 CD, Ar\u00f3stegui JI, Martin TM, Espada G, Scalzi L, Yag\u00fce J, et al. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a National cohort in Spain. Arthritis Rheum. 2009;60:1797\u2013803. https:\/\/doi.org\/10.1002\/art.24533.","journal-title":"Arthritis Rheum"},{"key":"528_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10067-017-3758-7","volume":"37","author":"D Wu","year":"2018","unstructured":"Wu D, Shen M. Two Chinese pedigrees of Blau syndrome with thirteen affected members. Clin Rheumatol. 2018;37:265\u201370. https:\/\/doi.org\/10.1007\/s10067-017-3758-7.","journal-title":"Clin Rheumatol"},{"key":"528_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.37776","volume":"65","author":"G Simonini","year":"2013","unstructured":"Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, et al. Clinical and transcriptional response to the long-acting interleukin-1 blocker Canakinumab in Blau syndrome-related uveitis. Arthritis Rheum. 2013;65:513\u20138. https:\/\/doi.org\/10.1002\/art.37776.","journal-title":"Arthritis Rheum"},{"key":"528_CR23","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1002\/art.22966","volume":"56","author":"JI Ar\u00f3stegui","year":"2007","unstructured":"Ar\u00f3stegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 Blockade in a Spanish cohort. Arthritis Rheum. 2007;56:3805\u201313. https:\/\/pubmed.ncbi.nlm.nih.gov\/17968944.","journal-title":"Arthritis Rheum"},{"key":"528_CR24","doi-asserted-by":"publisher","first-page":"1211240","DOI":"10.3389\/fimmu.2023.1211240","volume":"14","author":"Y Ueki","year":"2023","unstructured":"Ueki Y, Takimoto-Ito R, Saito MK, Tanizaki H, Kambe N. Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome. Front Immunol. 2023;14:1211240. https:\/\/doi.org\/10.3389\/fimmu.2023.1211240.","journal-title":"Front Immunol"},{"key":"528_CR25","doi-asserted-by":"publisher","first-page":"1759720X2210932","DOI":"10.1177\/1759720X221093211","volume":"14","author":"C \u00c1lvarez-Reguera","year":"2022","unstructured":"\u00c1lvarez-Reguera C, Prieto-Pe\u00f1a D, Herrero-Morant A, S\u00e1nchez-Bilbao L, Mart\u00edn-Varillas JL, Gonz\u00e1lez-L\u00f3pez E, et al. Clinical and immunological study of Tofacitinib and baricitinib in refractory Blau syndrome: case report and literature review. Therapeutic Adv Musculoskelet Disease. 2022;14:1759720X221093211. https:\/\/doi.org\/10.1177\/1759720X221093211.","journal-title":"Therapeutic Adv Musculoskelet Disease"},{"key":"528_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12969-021-00634-x","volume":"19","author":"S Zhang","year":"2021","unstructured":"Zhang S, Cai Z, Mo X, Zeng H. Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients. Pediatr Rheumatol Online J. 2021;19:160. https:\/\/doi.org\/10.1186\/s12969-021-00634-x.","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-026-00528-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-026-00528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-026-00528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:03:41Z","timestamp":1773795821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42358-026-00528-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1186\/s42358-026-00528-0","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}